Immune cell therapy brings good news again! After the Ministry of Health and Welfare released immune cells for clinical treatment of various cancers, domestic biomedical companies introduced the patented technologies of "DC (Dendritic Cell) Cancer Vaccine" and "Super NK (Natural Black Cell)" which were successfully developed in Japan, so that cancer patients in Taiwan Province Province did not have to travel to Japan for medical treatment.
Using Japanese immune cell culture technology, 22 kinds of cancers and100000 cancer patients were transferred to Taiwan Province province.
In the past, many cancer patients in Taiwan Province Province had to go to Japan for autoimmune cell therapy due to the restriction of laws and regulations, which was not only expensive, but also a long way. Nowadays, the Administrative Measures for the Implementation or Use of Medical Devices for Specific Medical Technology Testing has been officially promulgated and implemented. How the immune cell preparation industry and clinical treatment technology can really benefit patients from cell therapy has become an important link.
The "DC (Dendritic Cell) Cancer Vaccine" therapy was developed by the University of Tokyo. In Japan, there are 22 kinds of cancers, with more than 65438+ 1 000 cancer patients, including pancreatic cancer, colorectal cancer with the largest number of new cases and lung cancer with the largest number of deaths in China.
The command tower of immune cells in dendritic cell vaccine guides lymphocytes to attack cancer cells.
Professor Naokita Yamashita, an emeritus professor at the University of Tokyo, pointed out that dendritic cells are cells called "command towers". Dendritic cells will present cancer cell markers on the surface after swallowing cancer cells, and then activate and educate lymphocytes to recognize cancer cells. Guided lymphocytes will patrol the body, looking for cells with cancer markers and further attacking them to shrink cancer tumors. This is the principle of dendritic cell therapy.
Dendritic cells combine with effective cancer antigens to direct T cells to heat "cold" tumors!
Professor Naoki Yamashita also believes that if more accurate tumor antigen and dendritic cell therapy can be combined in the future, it is also expected that immune checkpoint inhibitors will play their greatest role! Professor Hiroyuki Yamashita pointed out that tumor immune checkpoint inhibitors are not effective for all tumors or all cancer patients. One of the key questions is how many T lymphocytes are responsible for the attack in cancer tissues! This is the difference between the so-called "hot tumor" and "cold tumor"!
He explained the new concept of cancer immunotherapy by comparing melanoma tissue with pancreatic cancer tissue slices. He pointed out that there are many T cells in melanoma tissue sections, which are called "hot tumors", while almost no T cells are detected in pancreatic cancer sections, which are called "cold tumors". When the immune checkpoint inhibitor clears the brakes of T cells, hot tumors filled with T cells are easily cleared by activated T cells, but cold tumors do not respond because there are no T cells to attack. He believes that if a more accurate and personalized antigen combination can be developed in the future, combined with dendritic therapy, and the tumor will turn from cold to hot, it is expected that the immune checkpoint inhibitor will play its greatest role!
"Super NK cells" specially trained the * * * immune cell troops to March into cancer with sea tactics.
In addition to dendritic cell vaccine, super NK cells also have experience of combined chemotherapy and targeted therapy in Japan, which has a positive effect on reducing side effects, relieving pain, enhancing immunity, strengthening physical strength and poisoning cancer cells. Together with dendritic cell vaccine, the company's two preparations have more than100000 cancer treatment experience in Japan.
Professor Lai, executive director of Taiwan Province Cancer Foundation and director of hospital cancer center, pointed out that NK cells provided by immune cell therapy, like various armed forces, form a sea of people to attack cancer cells. After the implementation of special management measures, as long as the GTP laboratory with qualified culture and amplification equipment manufactures the cell products used, it will have the opportunity to treat cancer patients through application. It is a shot in the arm of immune cell therapy, and it is believed that immune cell therapy will develop more vigorously in the foreseeable future.
Join us and pay attention to your health every day! Line @ ID: @ Subscribe to Health Aloha Audio-visual Channel to read health knowledge more easily: /supply/article/39527 Keywords: Ministry of Health and Welfare, Gulf Cancer Foundation, Hospital, Cancer Center, Lai, Super NK Cell.